James Edgemond
2021
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $481,573 |
|---|---|
| Non-Equity Incentive Plan | $679,688 |
| Salary | $721,154 |
| Other | $20,800 |
| Total | $1,903,215 |
Edgemond received $721.2K in salary, accounting for 38% of the total pay in 2021.
Edgemond also received $481.6K of change in pension value and nonqualified deferred compensation earnings, $679.7K in non-equity incentive plan and $20.8K in other compensation.
Rankings
In 2021, James Edgemond's compensation ranked 6,220th out of 12,415 executives tracked by ExecPay. In other words, Edgemond earned more than 49.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,220 out of 12,415 | 50th |
Division Manufacturing | 2,636 out of 5,508 | 52nd |
Major group Chemicals And Allied Products | 1,153 out of 2,378 | 52nd |
Industry group Drugs | 1,025 out of 2,099 | 51st |
Industry Pharmaceutical Preparations | 743 out of 1,549 | 52nd |
Pay ratio
| James Edgemond's Pay | $1,903,215 |
|---|---|
| Median Employee's Pay | $189,023 |
| Pay Ratio | 10to 1 |
In 2021, the annual total compensation of James Edgemond was $1,903,215.
The annual total compensation of the median employee at United Therapeutics was $189,023.
The ratio of James Edgemond's pay to the pay of median employee was therefore 10 to one.
Edgemond's colleagues
We found three more compensation records of executives who worked with James Edgemond at United Therapeutics in 2021.